An Effective Technique for Salvage of Cardiac-Related Devices by Knepp, Erin K. et al.
An Effective Technique for Salvage
of Cardiac-Related Devices
Erin K. Knepp, BS, Karan Chopra, BA, Hamid R. Zahiri, DO, Luther H. Holton III,
MD and Devinder P. Singh, MD
Division of Plastic Surgery, University of Maryland Medical Center, Baltimore
Correspondence: dsingh@smail.umaryland.edu
Published January 24, 2012
Millions of patients require implantable cardiac devices for management of cardiac dys-
rhythmias. These devices are susceptible to erosion, exposure, or infection and plastic
surgeons are consulted when salvage is required. As of yet, an anterior muscle-splitting
approach to effectively and safely relocate the device into the subpectoral position has
not been described in the plastic surgery literature. The authors retrospectively reviewed
the charts of 7 patients who required repositioning of cardiac devices. Indications for
repositioning included exposure, erosion, infection, hematoma at the time of primary
placement (3), and one cosmetic revision. All patients were treated with subpectoral
repositioning of the device into the subpectoral space via an anterior muscle-splitting
approach. Six of 7 patients (86%) achieved successful long-term repositioning in the
subpectoral position without recurrent exposure or hematoma and with good cosmetic
results. One patient who had a prior history of multiple failed device placements re-
quired reoperation due to recurrent infection. The anterior muscle-splitting technique
proposed by the authors for deﬁbrillator or pacemaker salvage is a feasible technique
with promising results. Plastic surgeons should be aware of this simple and effective
approach.
The development of sophisticated medical technologies parallels the growth in
American life expectancy. In particular, the evolving design of implantable cardiac de-
vices such as pacemakers and automatic internal cardiac deﬁbrillators has improved the
management of patients prone to debilitating dysrhythmias. Every year, nearly 300 000
new patients in the United States require implantable cardiac devices.1 While these devices
have undergone vast improvements in terms of design and size, they are foreign bodies
nonetheless and thus susceptible to complications including exposure, pain, palpability,
and infection. The reported incidence of infection ranges from 2 to nearly 20% of cases.2-8
These types of complications require either complete or partial removal and replantation of
the device and often its associated leads.
Traditionally, cardiac electrophysiologists perform primary implantation of these de-
vices. These practitioners tend to favor a subcutaneous site of implantation in the chest that
obviates dissection of deeper tissues. While this approach is well tolerated by most patients
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andthesubcutaneousspaceisconvenientlyaccessibletotheimplantingelectrophysiologist,
it is not appropriate for all patients. For example, in patients who are cachectic, primary
device placement into the subcutaneous space of the infraclavicular chest can lead to a
visible deformity that may be unacceptable or intolerable (Fig 1).
Figure 1. Impending generator exposure in cardiac cachexia.
In the case of device infection, pain, palpability, or exposure (Fig 2), plastic surgeons
may be consulted for salvaging or reimplanting the device. Removal of the device can
cause devastating complications such as venous, valvular, or atrioventricular (AV) injury,
tamponade, and sudden cardiac death.9,10 The morbidity and mortality associated with
device explantation may outweigh that of attempted salvage surgery.11
While other methods for in situ salvage exist, the authors implement a method of
salvage that maintains the original access incision while safely placing the salvaged device
and/or leads into a fresh and well-vascularized tissue plane. Speciﬁcally, this technique
relocates the device beneath the pectoralis major muscle via an anterior muscle-splitting
approach.
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Figure 2. Exposure of atrioventricular lead.
METHODS
Theauthorsretrospectivelyreviewedthechartsof7patientswhopresentedwithimpending
or frank exposure, infection, cosmetic concerns, or hematoma at the time of primary
placement by cardiology. All patients were treated with subpectoral repositioning via a
muscle-splitting approach. The patients were treated over a 36-month period between
August 2008 and August 2011 (mean follow-up, 21 months). The institutional review
board approved this study.
SURGICAL TECHNIQUE
Patients underwent salvage surgeries under sterile technique with intravenous (IV) sedation
and local anesthesia in the electrophysiology cardiology laboratory. Initial debridement of
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the pocket involved resection of necrotic skin and subcutaneous tissue overlying the old
generator, and evacuation of any hematoma or periprosthetic infection, abscesses, or puru-
lence. The surgical team then externalized and disconnected the devices from indwelling
AV leads and performed a partial or total capsulectomy. The capsulectomy required metic-
ulous dissection to skeletonize the leads, especially as they approach their entry into the
subclavian system. After capsulectomy, the resulting pocket was copiously irrigated with
antibiotic solution and inspected for hemostasis. Dissection was carried to the base of the
pocketwherethefasciaofthepectoralismajormusclewasencounteredandthemusclewas
incised in the orientation of its ﬁbers. A muscle-splitting approach was employed to divide
the pectoralis major muscle and identify the subpectoral space. Once identiﬁed, a pocket
was developed subpectorally using a combination of blunt dissection and electrocautery.
At the base of the pocket, the pectoralis minor muscle was left unperturbed. For medial
pockets or dissections, particular care was exercised to avoid disruption of neighboring
perforators of the underlying internal mammary artery and vein. Throughout the process,
awareness and preservation of the cephalic vein and identiﬁcation of the pectoral branch
of the thoracoacromial trunk are paramount. Once a satisfactory subpectoral pocket was
created, a new cardiac electrical generator unit was placed and connected to the preexisting
AV lead system (Fig 3). Next, the device was interrogated by the electrophysiology cardi-
ology service. Muscle was then closed primarily over the device with 3-0 vicryl ﬁgure-of-8
absorbable sutures. A closed suction drainage catheter was left in the subcutaneous space
and brought out through a remote incision. Meticulous layered closure of the subcutaneous
tissue was performed to obliterate dead space in the original superﬁcial pocket. Speciﬁ-
cally, 3-0 vicryl absorbable sutures were to close Scarpa’s fascia followed by interrupted
3-0 vicryl buried dermal sutures. Lastly, the skin was closed using a running 4-0 monocryl
continuous subcuticular stitch (Fig 4). Incision was dressed using Steri strips, telfa pads,
and ﬁnally tegaderm ﬁlm.
RESULTS
BetweenJuly2008andAugust2011,atotalof7patientsweretreated.Therewere5women
and2menwithameanageof59years(range,31-80yearsold).Inallcases,muscle-splitting
technique was performed without intraoperative complications. The mean follow-up was
21 months (range, 9-35 months). Indications for subpectoral repositioning of the cardiac
device included impending exposure (1), erosion (1), infection (1), hematoma at the time
of initial placement by primary service (3), and cosmesis (1). Six patients (86%) achieved
long-term successful repositioning of the generator in the subpectoral position with no
recurrentinfectionorexposure,andwithgoodcosmeticresults.Only1patienthadafailure
of treatment due to a recurrent open wound and wire exposure 2 months postoperatively.
In this case, failure was attributed to a 14-year-old lead that was not exchanged at the
time of device salvage. This patient had a history of several failed device placement
in bilateral subcutaneous locations secondary to infection requiring replantation by the
cardiac electrophysiology service. After the authors salvaged the device with subpectoral
repositioning,recurrentinfectiondevelopedwithapositivewoundcultureforEnterobacter
cloacae. Because of the recurrent history of infection with device placement in the chest
wall,theauthorschosetoplaceanewdeviceandleadsystemintheabdominalsubcutaneous
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tissue of the right lower quadrant. The patient was successfully treated with IV antibiotics
and did not develop subsequent infection.
Figure 3. Anterior muscle-splitting approach to subpectoral place with generator
replacement.
Figure 4. Immediate closure after subpectoral placement.
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DISCUSSION
Subpectoral positioning of cardiac devices is not a novel concept. In fact, techniques for
subpectoral positioning of cardiac devices using a lateral approach have been described.12
Furthermore, comparison of primary placement of cardiac devices in the subpectoral space
versus the traditional subcutaneous space was investigated.13 Results demonstrated no
signiﬁcant differences in freedom from complications. Thus, the current practice adopted
by most electrophysiology laboratories is to place these devices into the subcutaneous
space allowing shorter procedural time and requiring less demanding technical maneuvers.
Cardiac electrophysiologists can easily and quickly access the subcutaneous space without
the need for plastic surgery consultation.
There is a paucity of literature on the management of infected devices or devices that
areexposedbecauseofeithererosionthroughtheoverlyingskinorsecondarytopoorwound
healing. Device explantation is often not feasible because of risks including sudden cardiac
death. For this reason, salvage by repositioning of these infected or exposed cardiac devices
often becomes imperative in managing patients with debilitating cardiac arrhythmias.
Less data has been published on techniques used for device salvage in the setting of
infection or device erosion. Several authors have independently reported successful out-
comes with treated infected device pockets. Taylor and colleagues14 reported the treatment
of pacer pocket infections with revision and placement of a continuous irrigation system.
Hurst et al treated infected device pockets in a similar fashion with the use of closed
antibiotic irrigation for lead preservation. Lee’s group reported success with treating in-
fected device pockets via revision followed by placement of continuous irrigation system
and closed antibiotic irrigation.15-17 These approaches, however, do not move the device
to a sterile plane of tissue; thus, long-term sterility after discontinuation of the antibiotic
irrigation systems is questionable.
Anothergroup,Kolkeretal,18 presented6patientstreatedwithdebridement,capsulec-
tomy, and local rhomboid skin ﬂap closures; 83% achieved long-term successful salvage.
This technique carries the risk of additional donor site morbidity since adjacent tissue must
beharvestedandrotatedintotheprimarydefect.YamadareportedsuccessfulsalvageofAV
lead systems, in 17 of 18 patients, using pocket debridement, iodine packing, and creation
of an entirely new remote pocket.19 A success rate of 74% with pocket debridement, lead
preservation,andcreationofanewipsilateralsubcutaneouspocketinpatientswithnegative
woundcultureswasnotedbyGrifﬁth.20 Withthesestrategies,however,theriskofinfection,
erosion, or exposure may not be signiﬁcantly reduced as the cardiac device is still placed
within the prepectoral space. Har-Shai et al21 described a technique for subcapsular relo-
cation of the generator and lead systems. While this may be an effective salvage method,
subcapsular tissue coverage is less bulky and durable than the pectoralis major muscle,
making this technique subject to more complications.
As mentioned previously, subpectoral positioning for device salvage has been de-
scribed. In 1995, Foster12 described successful subpectoral placement in 6 patients, using a
lateral axillary approach. Soon after, Jenson22 described a case report of the repositioning
of an implantable generator from an abdominal pocket to a subpectoral location, using an
axillary tunneling technique. In 2004, Kistler et al23 reported on anatomic ﬁndings discov-
ered upon device recall surgery, implying that implant location was, in fact, “intrapectoral,”
located in a medial position between the 2 heads of pectoralis major muscle.
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Most recently in 2010, Al-Bataineh et al24 described a lateral axillary approach to
the subpectoral plane in patients with ipsilateral prepectoral infection and limited venous
access.Theyreportednorecurrenceofinfection,butonehematomaandonepneumothorax
in 16 patients treated. Most importantly, techniques describing a lateral axillary approach
have lacked a discussion regarding the effect on nipple sensation, which is a concern in any
lateral axillary pectoral approach as the anterolateral cutaneous branch of T4 intercostal
nerve is at risk here.25,26
Our series demonstrates comparable overall success with true subpectoral positioning
of implantable cardiac devices. Analysis of our 7 cases, with indications related to impend-
ing or frank exposure, infection, hematoma, and cosmesis, revealed an 86% success rate
with subpectoral repositioning with 21-month mean follow-up.
Important advantages of the anterior muscle-splitting technique include the ability to
repositionthedeviceintoacleanplane,coveragewithhealthyvascularizedmuscle,andthat
even with debridement of necrotic skin and subcutaneous tissue, skin of the original pocket
is easily closable over drains by means of simple undermining without the need for local
ﬂaps. The results demonstrated no hematoma or pneumothoraces, and nipple sensation is
not at risk with this approach. All surgeries were performed safely under IV sedation with
local anesthesia in the electrophysiology laboratory allowing for easy access to ﬂuoroscopy
and interrogation software. This facilitated a collaborative approach between cardiology
andplasticsurgeryallowingfordeviceexchangeandsubpectoralplacementsimultaneously
in the electrophysiology laboratory.
Likepreviousreportsofsecondaryrepositioningofcardiacdevicesintothesubpectoral
position, our series is retrospective and our sample size is low. Therefore, it is difﬁcult to
draw stringent conclusions. Our results match existing data outcomes and demonstrate a
safe approach to the subpectoral space with minimal morbidity.
As in the treatment of any infected prosthesis, if explantation of an infected device is
not possible, then aggressive debridement, obliteration of all dead space, and coverage with
healthy vascularized tissue such as muscle ﬂaps are essential principles of management.
There is a wide spectrum of treatment options (see Table 1), and reconstructive choices
should be tailored to individual clinical situations. Our series demonstrates that salvage
of cardiac devices with anterior muscle-splitting subpectoral repositioning is a technically
feasible approach with favorable outcomes and low morbidity. Plastic surgeons should be
aware of this simple and effective approach.
Table 1. Summary of management options
Device explantation and externalization
Debridement and local wound care with closed irrigation system
Revision of subcutaneous pocket and local skin ﬂap closure
Repositioning to distant subcutaneous location
Repositioning to subcapsular location
Repositioning to intrapectoral location
Repositioning to subpectoral position by axillary approach
Repositioning to subpectoral position by anterior muscle-splitting approach
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